Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?

about

Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?

Item

http://www.wikidata.org/entity/Q40719468

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Utilization of anticoagulants ...... rin plus GPI or heparin alone?

@en

type

Item

label

Utilization of anticoagulants ...... rin plus GPI or heparin alone?

@en

prefLabel

Utilization of anticoagulants ...... rin plus GPI or heparin alone?

@en

P1476

Utilization of anticoagulants ...... rin plus GPI or heparin alone?

@en

P2093

Michael Mitchell

http://www.w3.org/2001/XMLSchema#string

Robert Werner

http://www.w3.org/2001/XMLSchema#string

Stephanie Plent

http://www.w3.org/2001/XMLSchema#string

Weihong Fan

http://www.w3.org/2001/XMLSchema#string

P2860

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

Bivalirudin during primary PCI in acute myocardial infarction

A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011.

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Guidelines on myocardial revascularization.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.

P304

164-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21548331.2015.1065703

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26190670

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation